EYPT

Earnings Summary: EyePoint (EYPT) Q4 2025 net loss widens

6 hours ago

EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results…

4 years ago

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q2 2022 Earnings Conference

4 years ago

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q1 2022 Earnings Conference

4 years ago

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q4 2021 Earnings Conference

4 years ago

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q3 2021 Earnings Conference

5 years ago

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q2 2021 Earnings Conference